SCHEMBL7080583

SCHEMBL7080583

CCc1cc(CN[N]c2ccc(Cl)c(CC)c2)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
SLC6A4 P31645 3/20 0.39
HTR2A P28223 2/20 0.39
KCNH2 Q12809 2/20 0.39
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
FFAR1 O14842 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 1/20 0.35
LMNA P02545 2/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
CSNK2A3 Q8NEV1 1/20 0.34
IDO1 P14902 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.33
NLRP1 Q9C000 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790563 0.73 TRPA1 (0.43) SMN1; SMN2SLC6A4HTR2AKCNH2L3MBTL1
SCHEMBL24258323 0.70 KMT2A (0.47) SMN1; SMN2KCNH2NPSR1ALDH1A1
SCHEMBL7080588 0.70 IDO1 (0.43) TSHRSMN1; SMN2SLC6A4HTR2AKCNH2
SCHEMBL91286 0.69 POLB (0.40) TSHRSMN1; SMN2SLC6A4HTR2AKCNH2
SCHEMBL13179975 0.69 L3MBTL1 (0.39) TSHRSMN1; SMN2SLC6A4HTR2AKCNH2
SCHEMBL5847393 0.69 L3MBTL1 (0.39) TSHRSMN1; SMN2SLC6A4HTR2AKCNH2
SCHEMBL5847395 0.69 CSNK2A1 (0.57) L3MBTL1CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL3759408 0.69 L3MBTL1 (0.39) TSHRSMN1; SMN2SLC6A4HTR2AKCNH2
SCHEMBL281996 0.68 MAPK1 (0.63) TSHRSLC6A4HTR2AKCNH2L3MBTL1
SCHEMBL91283 0.67 GPR84 (0.44) TSHRSMN1; SMN2SLC6A4HTR2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030236257-A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade PHARMACIA CORPORATION 2003-12-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236257-A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade PLG, TFPI, PLAT TSHR 2319/4885SMN1; SMN2 3924/4885SLC6A4 1336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.